Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Guangdong Branch Of China Tobacco Gen Co. Ltd. has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to a distinct examiner and is located in 1 distinct art unit. This indicates a singular technical focus for the company's current prosecution activity. The concentration of the portfolio in a single art unit suggests a specific technical focus within the biotechnology field.
The busiest examiner for the portfolio is ZHANG SPIERING, DONGXIU, who is handling 1 pending office action. This represents the total volume of pending office actions for the company. Because there is only one distinct examiner and one distinct art unit, the prosecution strategy is centralized. Practitioners should focus on the specific examination patterns of ZHANG SPIERING, DONGXIU and the standards of the art unit.
The presence of the pending office action in the Biotechnology & Pharmaceuticals sector suggests a focused approach to intellectual property. For a practitioner, this concentration simplifies the management of the portfolio but increases the impact of the individual examiner's perspective. Success will depend on a deep understanding of the art unit's prior art landscape and the examiner's past behavior.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZHANG SPIERING, DONGXIU | 1 | 45.2% | +70.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18745813 | BACILLUS VELEZENSIS DRY SUSPENDING AGENT AND PREPARATION METHOD THEREOF | ZHANG SPIERING, DONGXIU | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18745813 | BACILLUS VELEZENSIS DRY SUSPENDING AGENT AND PREPARATION METHOD THEREOF | ZHANG SPIERING, DONGXIU | — |
| Art Unit | Apps |
|---|---|
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18745813 | BACILLUS VELEZENSIS DRY SUSPENDING AGENT AND PREPARATION METHOD THEREOF | ZHANG SPIERING, DONGXIU | 1616 | §102§112 | Non-Final OA | — | Pending | Jun 17, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial